Arkolith/Insider Trading/ZIVO/Form 4

Maggiore Christopher D.

Director, 10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Apr 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$325
Net Open-Market Flow
-$325
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2025Sell(S)20$16.25$325507K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-25-004085) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML